Aytu BioPharma, Inc.
Price Action
Technical Summary
CONSOLIDATINGAytu BioPharma, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 42), showing significant lag compared to the market leaders. Earnings contraction of 352% provides fundamental context to the price action. Investors should exercise caution due to high volatility (56% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.20 | +2.20% | ABOVE |
| 50 SMA | $2.35 | -4.08% | BELOW |
| 100 SMA | $2.43 | -7.38% | BELOW |
| 150 SMA | $2.43 | -7.37% | BELOW |
| 200 SMA | $2.37 | -5.26% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AYTU in an uptrend right now?
AYTU has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is AYTU overbought or oversold?
AYTU's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is AYTU outperforming the market?
AYTU has a Relative Strength (RS) Rating of 42 out of 99. AYTU is currently lagging the broader market.
Where is AYTU in its 52-week range?
AYTU is trading at $2.25, which is 73% of its 52-week high ($3.07) and 42% above its 52-week low ($1.65).
How volatile is AYTU?
AYTU has a Beta of 0.98 and 52-week volatility of 56%. It's less volatile than the S&P 500 - generally more stable.